College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA.
Am J Pharm Educ. 2011 Feb 10;75(1):1. doi: 10.5688/ajpe7511.
To describe the development and assessment of monographs as an assignment to incorporate evidence-based medicine (EBM) and pharmacoeconomic principles into a third-year pharmacoeconomic course.
Eight newly FDA-approved drugs were assigned to 16 teams of students, where each drug was assigned to 2 teams. Teams had to research their drug, write a professional monograph, deliver an oral presentation, and answer questions posed by faculty judges. One team was asked to present evidence for inclusion of the drug into a formulary, while another team presented evidence against inclusion.
The teams' average score on the written report was 99.1%; on the oral presentation, 92.5%, and on the online quiz given at the end of the presentations, 77%.
Monographs are a successful method of incorporating and integrating learning across different concepts, as well as increasing relevance of pharmacoeconomics in the PharmD curriculum.
描述专题论文的开发和评估,将循证医学(EBM)和药物经济学原理纳入到第三年的药物经济学课程中。
将 8 种新获得 FDA 批准的药物分配给 16 个学生小组,每个药物分配给 2 个小组。小组必须研究他们的药物,撰写专业的专题论文,进行口头报告,并回答教师评委提出的问题。一组被要求提出将药物纳入处方集的证据,而另一组则提出反对纳入的证据。
书面报告的小组平均得分为 99.1%;口头报告得分为 92.5%,在演示结束时进行的在线测验中得分为 77%。
专题论文是一种成功的方法,可以将不同概念的学习结合起来并整合起来,同时增加药物经济学在 PharmD 课程中的相关性。